<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163158">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00974194</url>
  </required_header>
  <id_info>
    <org_study_id>SPoCOT_2009</org_study_id>
    <nct_id>NCT00974194</nct_id>
  </id_info>
  <brief_title>Safety and Cost-effectiveness Study of Single Port Laparoscopic Cholecystectomies</brief_title>
  <acronym>SPoCOT</acronym>
  <official_title>Single Port vs Tree Trocars Laparoscopic Cholecystectomy: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many feasibility studies have been published on Single Port surgery, but no comparative
      studies have shown any advantages compared to standard laparoscopy. The purpose of this
      study is to compare the clinical outcomes and economical issues of laparoscopic
      cholecystectomies using single port transumbilical approach and three trocars.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design:

        -  Prospective Randomized Controlled trial

        -  Population analysis based on Intention To Treat

        -  Patient and data analyzer blinded (double-blind trial)

      Outcomes observed:

        -  Primary: pain

        -  Secondaries: overall operative time, complication rate, cost-effectiveness analysis,
           cosmetic evaluation, quality of life, CO2 consumption

      Nbr of patients included: 260

      Port used: Triport, Olympus
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>3 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Operative day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost analysis</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic results</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic results</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic results</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Cholecystolithiasis</condition>
  <arm_group>
    <arm_group_label>SinglePort CCK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CCK using Triport</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LS CCK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CCK using three or four trocars</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single Trocar CCK</intervention_name>
    <description>CCK using Triport</description>
    <arm_group_label>SinglePort CCK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard CCK</intervention_name>
    <description>CCK using three or four ports</description>
    <arm_group_label>LS CCK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cholecystolithiasis

          -  Age 18 to 75 y.o.

          -  BMI &lt; 35

        Exclusion Criteria:

          -  Immunodeficiency

          -  Choledocholithiasis

          -  Previous upperGI open surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Allemann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHV/CHUV</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Allemann, MD</last_name>
    <phone>+41213147526</phone>
    <email>pierre.allemann@chuv.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Lausanne</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Allemann, MD</last_name>
      <phone>+41213147526</phone>
      <email>pierre.allemann@chuv.ch</email>
    </contact>
    <investigator>
      <last_name>Pierre Allemann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrien Tempia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nermin Halkic, MD, MER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas Demartines, MD, FACS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.chirurgieviscerale.ch</url>
    <description>Internet page of our departement</description>
  </link>
  <verification_date>December 2014</verification_date>
  <lastchanged_date>December 3, 2014</lastchanged_date>
  <firstreceived_date>September 8, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Nicolas DEMARTINES</investigator_full_name>
    <investigator_title>professor of surgery</investigator_title>
  </responsible_party>
  <keyword>Cholecystolithiasis</keyword>
  <keyword>Cholecystectomy</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Single port</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
